Loading financial statements…
Import this data to Google Sheets with:
=jivedata("DAIO","financials")Full statements spill as a table. For one cell: =jivedata("DAIO","Revenue") or =jivedata("DAIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
DAIO • CIK 0000351998
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $28,064 | $21,769 | $21,500 | $17,775 |
| Cost of Goods and Services Sold | $11,878 | $10,163 | $10,904 | $8,782 |
| Gross Profit | $16,186 | $11,606 | $10,596 | $8,993 |
| Net Income (Loss) Attributable to Parent | $486 | $-3,093 | $-5,236 | $-8,911 |
| Weighted Average Number of Shares Outstanding, Basic | 8,941 | 9,150,000 | 9,329,000 | 18,802,733 |
| Weighted Average Number of Shares Outstanding, Diluted | 9,073 | 9,150,000 | 9,329,000 | 18,802,733 |
| Research and Development Expense | $6,524 | $6,240 | $6,531 | $6,025 |
| Selling, General and Administrative Expense | $9,214 | $8,404 | $9,181 | $10,732 |
| Operating Expenses | $15,738 | $14,644 | $15,712 | $16,757 |
| Operating Income (Loss) | $448 | $-3,038 | $-5,116 | $-7,764 |
| Interest Income, Other | — | $273 | $130 | $83 |
| Foreign Currency Transaction Gain (Loss), before Tax | $42 | $58 | $-10 | $-119 |
| Nonoperating Income (Expense) | $232 | $331 | $120 | $-909 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $680 | $-2,707 | $-4,996 | $-8,673 |
| Income Tax Expense (Benefit) | $194 | $386 | $240 | $238 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $12,341 | $10,326 | $7,901 | $10,843 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $5,707 | $3,960 | $2,841 | $4,302 |
| Inventory, Net | $5,875 | $6,212 | $5,710 | $6,189 |
| Other Assets, Current | $690 | $659 | $799 | $856 |
| Assets, Current | $24,613 | $21,157 | $17,251 | $22,190 |
| Property, Plant and Equipment, Net | $1,359 | $1,001 | $807 | $678 |
| Other Assets, Noncurrent | $1,429 | $2,812 | $2,118 | $1,774 |
| Assets | $27,401 | $24,970 | $20,176 | $24,642 |
| Other Accrued Liabilities, Current | $1,438 | $1,161 | $1,328 | $2,104 |
| Accrued Income Taxes, Current | — | $39 | $4 | $4 |
| Liabilities, Current | $6,188 | $5,072 | $4,981 | $11,484 |
| Operating Lease, Liability, Noncurrent | $703 | $2,064 | $1,411 | $1,056 |
| Other Notes Payable, Noncurrent | — | $112 | $20 | $0 |
| Accounts Payable, Current | $1,272 | $820 | $1,227 | $1,350 |
| Deferred Revenue, Current | $1,362 | $1,535 | $1,464 | $1,093 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Common Stock, Value, Issued | $22,731 | $23,475 | $24,062 | $25,916 |
| Retained Earnings (Accumulated Deficit) | $-2,645 | $-5,738 | $-10,974 | $-15,773 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $233 | $-111 | $426 | $544 |
| Stockholders' Equity Attributable to Parent | $20,319 | $17,626 | $13,514 | $11,852 |
| Accounts Receivable, Allowance for Credit Loss | $72 | $22 | $29 | $31 |
| Preferred Stock, Shares Authorized | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| Common Stock, Shares Authorized | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 |
| Common Stock, Shares, Issued | 9,020,819 | 9,236,040 | 9,391,922 | 10,395,627 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | $-5,236 | $-8,911 |
| Stock Issued During Period, Value, New Issues | — | — | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $-356 | $-232 | $-107 | $8,199 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | $877 | $-1,694 | $-2,892 | $607 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-46 | $-321 | $467 | $267 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $12,341 | $10,326 | $7,901 | $3,123 |
| Income Taxes Paid, Net | $171 | $459 | $10 | $-4 |
| Depreciation, Depletion and Amortization, Nonproduction | — | $564 | $495 | $475 |
| Payments to Acquire Property, Plant, and Equipment | $1,195 | $467 | $558 | $440 |
| Net Cash Provided by (Used in) Investing Activities | $-1,195 | $-467 | $-558 | $-432 |
| Share-based Payment Arrangement, Noncash Expense | $1,190 | $977 | $697 | $506 |
| Proceeds from Issuance of Common Stock | — | $-232 | $-107 | $-12 |
| Increase (Decrease) in Accounts Receivable | $-719 | $-1,711 | $1,214 | $2,866 |
| Increase (Decrease) in Inventories | $815 | $358 | $566 | $1,335 |
| Increase (Decrease) in Other Current Assets | $-48 | $-29 | $-135 | $-191 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | $109 | $-1,263 | $-76 | $271 |
| Increase (Decrease) in Deferred Revenue | $-267 | $122 | $-245 | $-184 |
| Increase (Decrease) in Other Noncurrent Liabilities | $-684 | $1,458 | $-749 | $-715 |
| Increase (Decrease) in Deposit Assets | $637 | $1,402 | $735 | $801 |
| Net Cash Provided by (Used in) Operating Activities | $2,428 | $-995 | $-2,227 | $-7,160 |